The Expert Institute for Parkinson’s Disease
Powered by
At Amneal, we’re committed to improving the lives of people with Parkinson’s disease. And a big part
of
that
is supporting those who are dedicated to their care. Which is why we created the Expert Institute for
Parkinson’s Disease (EIPD), a robust curriculum created in partnership with top specialists in the
field
of
movement disorders.
Where would you like to begin?
-
Learning LibraryInformation about pharmacokinetics, efficacy, and dosing of RYTARY® (carbidopa and levodopa) extended-release capsules. -
Upcoming EventsUpcoming events about treatment strategies, emerging therapies, and more. -
Featured Content
Duration of Benefit per Dose: RYTARY vs IR CD/LD
Hear Robert A. Hauser, MD, MBA, FAAN, discuss why he and his colleagues conducted the post hoc analysis of ADVANCE-PD.
-
Separating facts from fiction with RYTARY.
-
Optimizing extended-release carbidopa/levodopa in Parkinson disease: Consensus on conversion from standard therapy